Legal Representation
Attorney
Mark D. Hansing
USPTO Deadlines
Next Deadline
28 days remaining
NOA E-Mailed - SOU Required
Due Date
August 11, 2025
Extension Available
Until February 11, 2026
Application History
22 events| Date | Code | Type | Description |
|---|---|---|---|
| Feb 11, 2025 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Dec 17, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Dec 17, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Dec 11, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Nov 19, 2024 | GNEA | F | EXAMINERS AMENDMENT E-MAILED |
| Nov 19, 2024 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN |
| Nov 19, 2024 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Nov 19, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Nov 19, 2024 | XAEC | I | EXAMINER'S AMENDMENT ENTERED |
| Aug 23, 2024 | GNFR | O | FINAL REFUSAL E-MAILED |
| Aug 23, 2024 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Aug 23, 2024 | CNFR | R | FINAL REFUSAL WRITTEN |
| May 7, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| May 7, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| May 7, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Feb 19, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Feb 19, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Feb 19, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED |
| Feb 2, 2024 | DOCK | D | ASSIGNED TO EXAMINER |
| Oct 6, 2023 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Oct 5, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Sep 23, 2023 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
Eye drops and ophthalmological preparations
Class 042
Research and development of eye drops and ophthalmological preparations
Additional Information
Design Mark
The mark consists of a large, dark blue circle with a smaller red circle inside, with a green curved line above the dark blue circle and a blue curved line underneath the dark blue circle, resembling a stylized eye. Above the design is the word "REGENERATIVE", with the words "OCULAR IMMUNOBIOLOGICS" underneath the design, all in stylized, dark blue font, with the initial letter "R" in "REGENERATIVE", the letter "O" in "OCULAR", and the initial letter "I" in "IMMUNOBIOLOGICS" in bold font.
Color Claim
The color(s) blue, dark blue, red and green is/are claimed as a feature of the mark.
Classification
International Classes
005
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"REGENERATIVE OCULAR IMMUNOBIOLOGICS"
USPTO Documents
Loading USPTO documents...